<DOC>
	<DOC>NCT01587885</DOC>
	<brief_summary>This study will evaluate a single ingredient product (omeprazole 20 mg) with a combination product capsule (omeprazole 20 mg + sodium bicarbonate 1100 mg) in participants with frequent heartburn.</brief_summary>
	<brief_title>Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)</brief_title>
	<detailed_description />
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Omeprazole, sodium bicarbonate drug combination</mesh_term>
	<mesh_term>Molecular Mechanisms of Pharmacological Action</mesh_term>
	<criteria>Females of reproductive potential must demonstrate a negative urine pregnancy test and agree to use an acceptable method of birth control Suffer from frequent heartburn Refrain from taking nonstudy medicine or treatment for heartburn for the duration of the study Be free of any clinically significant disease that requires a physician's care Read and understand English Any significant medical condition which is a contraindication to the use of omeprazole or sodium bicarbonate Known hypersensitivity to the study drugs or any components Experiencing any of the following: trouble or pain with swallowing food, vomiting with blood, bloody or black stools Participation in another investigational study within 4 weeks prior to the screening visit.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Frequent Heartburn</keyword>
	<keyword>Omeprazole</keyword>
	<keyword>Omeprazole, sodium bicarbonate drug combination</keyword>
	<keyword>Gastrointestinal Agents</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Enzyme Inhibitors</keyword>
	<keyword>Molecular Mechanisms of Pharmacological Action</keyword>
	<keyword>Proton Pump Inhibitors</keyword>
</DOC>